Jane Street Group, LLC Myriad Genetics Inc Call Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$16.45 - $25.88 $639,905 - $1.01 Million	-38,900 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$22.67 - $28.01 $564,483 - $697,449	24,900 Added 177.86%	38,900 $980,000
Q3 2021 Nov 16, 2021	SELL	$29.97 - $36.66 $263,736 - $322,607	-8,800 Reduced 38.6%	14,000 $452,000
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $289,446 - $371,754	11,400 Added 100.0%	22,800 $697,000
Q1 2021 May 18, 2021	SELL	$19.92 - $31.6 $378,480 - $600,400	-19,000 Reduced 62.5%	11,400 $347,000
Q4 2020 Feb 17, 2021	BUY	$12.16 - $19.77 $154,432 - $251,079	12,700 Added 71.75%	30,400 $601,000
Q3 2020 Nov 17, 2020	SELL	$11.25 - $14.75 $56,250 - $73,750	-5,000 Reduced 22.03%	17,700 $231,000
Q2 2020 Aug 17, 2020	BUY	$10.69 - $16.49 $242,663 - $374,322	22,700 New	22,700 $257,000
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $202,446 - $611,271	-20,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $433,251 - $726,570	20,700 New	20,700 $564,000

230

88.9M

43.5K

18.1K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.